Boston, MA, United States of America

Nicholas Mitsiades


Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2018-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Nicholas Mitsiades

Introduction: Nicholas Mitsiades, based in Boston, MA, is an accomplished inventor in the field of medical research, particularly known for his significant contributions to cancer diagnosis and treatment. With two patents to his name, Mitsiades has been at the forefront of developing innovative methods that have the potential to improve patient outcomes in cancer care.

Latest Patents: Mitsiades holds two notable patents. The first patent, titled "Diagnostic/prognostic marker and therapeutic target for cancer," focuses on methods and compositions for the prognosis, diagnosis, and treatment of prostate and breast cancer. This patent highlights the importance of assessing TDRD1 expression levels, with specific emphasis on tailored therapies for individuals with overexpressed TDRD1 levels. The second patent, "SRC-2 use as a metabolic biomarker for diagnosis and treatment of metastatic prostate cancer," outlines approaches for treating prostate cancer, particularly in cases of metastatic progression. This innovation involves assaying for SRC-2 levels to provide effective therapy to individuals at risk for developing metastatic prostate cancer.

Career Highlights: Nicholas Mitsiades works at Baylor College of Medicine, where he continues to expand his research in cancer therapeutics. His role at such a prestigious institution underscores his commitment to advancing medical science and improving therapeutic strategies for cancer patients.

Collaborations: Mitsiades collaborates with esteemed colleagues in his field, including Bin He and Rainer B. Lanz. These partnerships exemplify the importance of teamwork in driving innovation and enhancing the scope of scientific research in oncology.

Conclusion: Nicholas Mitsiades is a prominent figure in cancer research, recognized for his innovative patents that focus on the early detection and effective treatment of prostate and breast cancers. His work at Baylor College of Medicine and collaborations with notable researchers exemplify his dedication to advancing medical technology and improving patient care. As cancer diagnosis and treatment evolve, Mitsiades’s contributions are poised to make a lasting impact in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…